| Cervical Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 34show all (up to 200) |
|---|
| → investigated in trials for | Cisplatinsmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |